Advanced Therapy Accelerator Tackles Continuous Manufacturing Challenges

Advanced Therapy Accelerator Tackles Continuous Manufacturing Challenges

A UK organization supporting advanced therapy innovation is working to implement continuous upstream processing for Adeno-Associated Viruses (AAV). The Cell and Gene Therapy Catapult has developed systems for high cell density transfection and for continuous perfusion. The group is now working to bring the component parts together. “We’ve assembled a platform for high density continuous harvest and shown some proof-of-concept data,” explains Mol…

INmune, CGT Catapult to set up manufacturing for cell therapy platforms

This collaboration primarily aims to concentrate on expediting production of the recessive dystrophic epidermolysis bullosa (RDEB) therapy CORDStrom. An independent technology and innovation organisation, CGT Catapult focuses on The post INmune Bio, CGT Catapult to set up manufacturing for cell therapy platforms appeared first on Pharmaceutical Business review.